News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘TranslationalResearch’ clear

  • In a major advance in the care of patients with leukemia and other blood disorders, physicians at Dana-Farber/Brigham and Women's Cancer Center have begun using Rapid Heme Panel, a high-tech genetic test that provides, within a matter of days, an unprecedented amount of critical information to aid the choice of treatment.

Tags: StemCellTransplant, TranslationalResearch, Leukemia

  • Sequencing a patient's tumor before and after a clinical trial yielded information on why the tumor responded to and eventually resisted treatment, identifying mutations that may help guide the treatment of patients with cancers with similar mutations.

Tags: TranslationalResearch, HeadNeckCancers

  • Dana-Farber researchers have demonstrated that a hormone-depleting drug can help eliminate or nearly eliminate aggressive prostate cancers that have yet to spread beyond the prostate.

Tags: Hormones, ProstateCancer, TranslationalResearch

  • A multi-institutional team of researchers has published a study that demonstrates a novel therapy works against solid tumors. It is the first targeted and programmed nanomedicine to enter human clinical studies.

Tags: TargetedTherapy, TranslationalResearch

  • By conducting simultaneous clinical trials in patients and labs, Dana-Farber researchers and colleagues have been able to predict how patients with non-small cell lung cancer respond to combination therapy.

Tags: LungCancer, TranslationalResearch

  • Jessie M. English, PhD, has been appointed the head of Research of the Belfer Institute for Applied Cancer Science at Dana-Farber. The Belfer Institute offers the full array of innovative drug discovery capabilities, from the identification of cancer-causing genetic mutations to the validation and selection of new drug targets.

Tags: Genomics, LungCancer, TargetedTherapy, TranslationalResearch

  • Two Dana-Farber researchers have been given an award for young investigators who are advancing the field of cancer research. Scott Armstrong, MD, PhD, is being recognized for achievements in cancer stem cell research and genomics; Kornelia Polyak, MD, PhD, for her pioneering discoveries in breast tissue.

Tags: BasicResearch, Honors, TranslationalResearch

  • Belfer Institute and sanofi-aventis scientists will work jointly with the goal of discovering new anticancer drugs targeted at specific patient populations.

Tags: TargetedTherapy, TranslationalResearch

  • The use of monoclonal antibodies to activate an immune-system response to abnormal cells resulted in a significant increase in survival time in patients with metastatic melanoma, report Dana-Farber researchers.

Tags: ImmuneSystem, Melanoma, TranslationalResearch

  • The FDA's approval of Provenge®, a prostate cancer vaccine, marks a new era of using patients' immune systems to treat cancer.

Tags: ImmuneSystem, ProstateCancer, TranslationalResearch, Immunotherapy

Showing 1-10 of 11 items